FDA Inspection
Annovex Pharma, Inc.FDA Inspection 1321164 - Annovex Pharma, Inc. - June 03, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns Annovex Pharma, Inc., with an inspection on June 3, 2026, issued by the Baltimore District Office, covering human drugs.
Open in Dashboard
ID · 6c5d97b2-604d-4817-85e1-9b4bc3a0471f
Violation Codes2
21 CFR 211.180(e)21 CFR 211.42(c)(10)(vi)
Full citation text and observation details available on the Dashboard.